Institutional investors hold a majority ownership of MRK through the 75.70% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BNP PARIBAS ARBITRAGE SNC Bought 394.9 Thousand shares of Merck
STATE STREET GLOBAL ADVISORS LTD... Bought 272.9 Thousand shares of Merck
NATIONAL PENSION SERVICE OF KORE... Bought 135.4 Thousand shares of Merck